Showing results (41-50 of 130) with videos related to
Sort By:
Pageof 13
Immunology Today|September 18, 1997
IL-6 and APPs: anti-inflammatory and immunosuppressive mediatorsH Tilg, C A Dinarello, J W MierJournal of the European Academy of Dermatology and Venereology : JEADV|August 24, 2007
Cheilitis granulomatosa and Melkersson-Rosenthal syndrome: evaluation of gastrointestinal involvement and therapeutic regimens in a series of 14 patientsG Ratzinger, N Sepp, W Vogetseder, et al.Digestive Diseases (Basel, Switzerland)|November 20, 2013
Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trialsR R Gerner, A R Moschen, H TilgGut|November 25, 2003
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitisH Tilg, H Vogelsang, O Ludwiczek, et al.Padiatrie Und Padologie|January 1, 1989
[Diagnosis and therapeutic strategies in pneumonia in childhood]R Schmitzberger, J P Guggenbichler, H Tilg, et al.Digestive Diseases (Basel, Switzerland)|September 14, 2013
Liver complications in inflammatory bowel diseasesV Wieser, R Gerner, A R Moschen, et al.European Cytokine Network|March 8, 2000
Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapyC Molnar, T Buratti, C J Wiedermann, et al.Current Topics in Microbiology and Immunology|June 28, 2007
CD1 expression on antigen-presenting cellsS K Dougan, A Kaser, R S BlumbergJournal of Nuclear Medicine Technology|May 17, 2008
CT artifact recognition for the nuclear technologistRobert Popilock, Kumar Sandrasagaren, Lowell Harris, et al.European Journal of Pediatrics|September 1, 1996
Circulating interleukin-1 receptor antagonist levels in neonatesR Geiger, H Ellemunter, F M Fink, et al.Pageof 13